Variant report

Variant	rs915772
Chromosome Location	chr21:45575628-45575629
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:45573335..45575799-chr21:45659324..45661159,2	MCF-7	breast:
2	chr21:45551834..45580791-chr21:45711953..45732193,97	MCF-7	breast:
3	chr21:45573470..45576200-chr21:45587990..45590480,2	MCF-7	breast:
4	chr21:45574056..45576001-chr21:45612468..45614888,2	MCF-7	breast:
5	chr21:45572891..45575841-chr21:45596465..45598354,2	MCF-7	breast:
6	chr21:45571309..45577111-chr21:45620650..45624145,5	MCF-7	breast:
7	chr21:45561894..45565955-chr21:45571282..45575871,6	MCF-7	breast:
8	chr21:45574132..45576452-chr21:45620912..45622702,2	MCF-7	breast:
9	chr21:45573193..45575716-chr21:45715248..45717300,2	K562	blood:
10	chr21:45574984..45576720-chr21:45588923..45590555,2	MCF-7	breast:
11	chr21:45573927..45576486-chr21:45579898..45582500,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000225331	Chromatin interaction
ENSG00000141959	Chromatin interaction
ENSG00000232124	Chromatin interaction
ENSG00000160223	Chromatin interaction

Extended variants
information (count: 133 )
Associated
traits (count: 2 )

rSNPs within LD-proxies of this variant (count:112)

rs_ID	r²[population]
rs1005046	0.90[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.94[YRI][hapmap];0.82[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs1059813	0.81[EUR][1000 genomes]
rs11089115	0.89[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.81[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs11089117	0.83[AMR][1000 genomes]
rs1131999	0.94[CHB][hapmap];0.83[JPT][hapmap]
rs11700840	0.87[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs11700972	0.85[JPT][hapmap]
rs12626672	0.80[AFR][1000 genomes];0.83[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs12627239	0.85[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs13046297	0.90[CEU][hapmap];0.94[CHB][hapmap];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs13048551	0.80[AFR][1000 genomes];0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs13049059	0.84[JPT][hapmap]
rs1858665	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2020945	0.85[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2020946	0.85[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2020948	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2071142	0.90[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.80[EUR][1000 genomes]
rs2071143	0.90[CEU][hapmap];0.94[CHB][hapmap];0.84[JPT][hapmap];0.81[EUR][1000 genomes]
rs2071146	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap];0.81[EUR][1000 genomes]
rs2071147	0.81[EUR][1000 genomes]
rs2071152	1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2073432	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2073433	0.90[CEU][hapmap];0.94[CHB][hapmap];0.81[JPT][hapmap];0.81[EUR][1000 genomes]
rs2073435	0.80[EUR][1000 genomes]
rs2156428	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs2238704	1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2238707	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2238711	1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2242950	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2242953	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap];0.80[EUR][1000 genomes]
rs2242954	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2243999	0.85[CEU][hapmap];1.00[CHB][hapmap];0.82[JPT][hapmap]
rs2245380	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2245386	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2245462	1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2245759	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2247400	1.00[CHB][hapmap];0.81[JPT][hapmap]
rs2251267	0.90[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.81[EUR][1000 genomes]
rs2255716	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2255828	0.85[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2256441	1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2276530	0.85[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2277806	0.85[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2299812	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2299815	0.85[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2299820	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2516519	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2516521	0.80[CEU][hapmap];1.00[CHB][hapmap]
rs2838468	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2838472	0.84[CHB][hapmap]
rs2838473	0.85[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2838476	1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2838477	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2838478	1.00[CHB][hapmap];0.90[JPT][hapmap]
rs2838482	0.85[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2838483	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2838485	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2838486	0.85[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap]
rs2838488	0.85[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs2838489	1.00[CHB][hapmap];0.85[JPT][hapmap];0.81[EUR][1000 genomes]
rs2838490	0.90[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.80[EUR][1000 genomes]
rs2838491	0.90[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.81[EUR][1000 genomes]
rs2838492	0.89[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap];0.81[EUR][1000 genomes]
rs2838493	0.84[CEU][hapmap]
rs2838494	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap];0.83[EUR][1000 genomes]
rs2838496	0.90[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];0.82[EUR][1000 genomes]
rs2838498	0.83[EUR][1000 genomes]
rs2838499	0.82[EUR][1000 genomes]
rs2838500	0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs2838501	0.83[AFR][1000 genomes]
rs2838502	0.84[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.86[YRI][hapmap];0.87[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs2838503	0.90[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];0.86[YRI][hapmap];0.90[AFR][1000 genomes];0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs2838507	0.81[CEU][hapmap]
rs2838511	0.85[CEU][hapmap];0.94[YRI][hapmap]
rs2850156	0.80[EUR][1000 genomes]
rs2850157	0.80[EUR][1000 genomes]
rs28547944	0.89[AFR][1000 genomes];0.92[AMR][1000 genomes];0.96[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2855652	0.80[EUR][1000 genomes]
rs35538274	0.82[EUR][1000 genomes]
rs3788097	0.94[CHB][hapmap];0.84[JPT][hapmap]
rs4818881	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap];0.82[EUR][1000 genomes]
rs4818882	0.81[AMR][1000 genomes];0.89[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs4819366	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs4819376	0.90[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.80[EUR][1000 genomes]
rs4819377	0.81[EUR][1000 genomes]
rs4819378	0.90[CEU][hapmap];1.00[CHB][hapmap];0.85[JPT][hapmap]
rs4819381	0.83[EUR][1000 genomes]
rs4819383	0.90[CEU][hapmap];0.90[AFR][1000 genomes];0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs71326035	0.81[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs7277269	0.85[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap]
rs7279319	0.81[AMR][1000 genomes];0.88[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs7279727	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs7280558	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.82[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs7280581	0.81[EUR][1000 genomes]
rs7281291	0.87[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs7281768	0.84[CEU][hapmap];0.94[CHB][hapmap];0.85[JPT][hapmap]
rs7282324	0.81[CEU][hapmap]
rs7283870	0.81[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs729882	1.00[CHB][hapmap];0.81[JPT][hapmap]
rs756554	0.90[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap]
rs756555	0.89[CEU][hapmap];0.82[CHB][hapmap]
rs8126564	1.00[CHB][hapmap];0.90[JPT][hapmap];0.83[EUR][1000 genomes]
rs8126958	0.88[CHB][hapmap];0.84[JPT][hapmap]
rs915774	1.00[CEU][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];0.94[AMR][1000 genomes];0.99[EUR][1000 genomes]
rs915878	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs9306171	1.00[CHB][hapmap];0.84[JPT][hapmap]
rs9306172	0.85[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap]
rs9680179	0.81[EUR][1000 genomes]
rs968713	0.81[CEU][hapmap]
rs968714	0.90[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.81[EUR][1000 genomes]
rs9975708	1.00[CHB][hapmap];0.85[JPT][hapmap]
rs9981257	1.00[CHB][hapmap];0.85[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:21 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv33817	chr21:45169412-46031810	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Strong transcription Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	121 gene(s)	inside rSNPs	diseases
2	nsv913887	chr21:45344799-45670770	Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	57 gene(s)	inside rSNPs	diseases
3	nsv1064420	chr21:45460089-45814986	Enhancers Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	67 gene(s)	inside rSNPs	diseases
4	nsv544472	chr21:45460089-45814986	Weak transcription Flanking Bivalent TSS/Enh Enhancers Strong transcription Bivalent Enhancer Active TSS Genic enhancers Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	67 gene(s)	inside rSNPs	diseases
5	nsv432155	chr21:45479055-45772388	Weak transcription Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
6	nsv913890	chr21:45482950-45603746	Genic enhancers Enhancers Active TSS Strong transcription Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
7	nsv459294	chr21:45499171-45595060	Active TSS Flanking Active TSS Strong transcription Genic enhancers Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
8	nsv587722	chr21:45499171-45595060	Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
9	nsv913891	chr21:45508561-45588518	Strong transcription Enhancers Active TSS Weak transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
10	nsv913892	chr21:45508561-45595060	Flanking Active TSS Enhancers Strong transcription Weak transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
11	nsv913893	chr21:45508561-45603746	Flanking Active TSS Strong transcription Genic enhancers Active TSS Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
12	nsv913894	chr21:45508561-45627976	Enhancers Strong transcription Active TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	34 gene(s)	inside rSNPs	diseases
13	nsv913895	chr21:45528919-45595060	Enhancers Weak transcription Genic enhancers Active TSS Strong transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
14	nsv913896	chr21:45528919-45603746	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
15	nsv913897	chr21:45528919-45640139	Strong transcription Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases
16	esv1825445	chr21:45535566-45754936	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
17	esv1817474	chr21:45540607-45773102	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	65 gene(s)	inside rSNPs	diseases
18	nsv533679	chr21:45551026-45768578	Enhancers Active TSS Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	64 gene(s)	inside rSNPs	diseases
19	nsv913898	chr21:45555079-45941566	Weak transcription Enhancers Active TSS Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	74 gene(s)	inside rSNPs	diseases
20	nsv428042	chr21:45560437-45848190	Enhancers Active TSS Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	61 gene(s)	inside rSNPs	diseases
21	nsv1065479	chr21:45571324-45617878	Weak transcription Enhancers Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases

mRNA abundance (count:2)

SNP	Gene	Cis/trans	Tissue	Source
rs915772	PWP2	Cis_1M	lymphoblastoid	RTeQTL
rs915772	PWP2	cis	Muscle Skeletal	GTEx

Chromatin state (count:94 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:45561000-45584400	Weak transcription	Aorta	Aorta
2	chr21:45565400-45580600	Weak transcription	Brain Germinal Matrix	brain
3	chr21:45570600-45577400	Enhancers	Primary B cells from cord blood	blood
4	chr21:45571000-45582600	Weak transcription	Ovary	ovary
5	chr21:45572400-45577400	Enhancers	Fetal Thymus	thymus
6	chr21:45572800-45577400	Enhancers	Primary hematopoietic stem cells	blood
7	chr21:45573000-45575800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr21:45573000-45576000	Enhancers	Brain Inferior Temporal Lobe	brain
9	chr21:45573000-45576000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
10	chr21:45573000-45576000	Enhancers	Fetal Heart	heart
11	chr21:45573000-45576000	Enhancers	Stomach Mucosa	stomach
12	chr21:45573000-45576000	Enhancers	HMEC	breast
13	chr21:45573000-45576800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
14	chr21:45573000-45577600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
15	chr21:45573000-45579400	Enhancers	Spleen	Spleen
16	chr21:45573200-45575800	Enhancers	Right Atrium	heart
17	chr21:45573200-45576000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
18	chr21:45573200-45576000	Enhancers	Psoas Muscle	Psoas
19	chr21:45573200-45577200	Enhancers	Sigmoid Colon	Sigmoid Colon
20	chr21:45573400-45575800	Enhancers	Left Ventricle	heart
21	chr21:45573400-45576800	Enhancers	Breast Myoepithelial Primary Cells	Breast
22	chr21:45573600-45579400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr21:45573600-45580000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr21:45573800-45577000	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr21:45573800-45577200	Enhancers	Brain Hippocampus Middle	brain
26	chr21:45573800-45577600	Enhancers	Colonic Mucosa	Colon
27	chr21:45573800-45578000	Enhancers	Placenta	Placenta
28	chr21:45573800-45580400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr21:45574000-45577000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
30	chr21:45574000-45577000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr21:45574000-45578000	Enhancers	Esophagus	oesophagus
32	chr21:45574000-45579200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr21:45574000-45579400	Weak transcription	Small Intestine	intestine
34	chr21:45574200-45575800	Genic enhancers	Fetal Intestine Small	intestine
35	chr21:45574200-45575800	Enhancers	HSMM	muscle
36	chr21:45574400-45575800	Enhancers	Gastric	stomach
37	chr21:45574400-45576000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr21:45574400-45577200	Enhancers	Brain Substantia Nigra	brain
39	chr21:45574600-45575800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
40	chr21:45574600-45575800	Enhancers	Fetal Intestine Large	intestine
41	chr21:45574600-45575800	Flanking Active TSS	GM12878-XiMat	blood
42	chr21:45574600-45579400	Weak transcription	Pancreas	Pancrea
43	chr21:45574800-45575800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
44	chr21:45574800-45575800	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
45	chr21:45574800-45576000	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
46	chr21:45574800-45576000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
47	chr21:45574800-45576000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr21:45575000-45575800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr21:45575000-45575800	Flanking Active TSS	Primary T cells from cord blood	blood
50	chr21:45575000-45575800	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links